Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5497
Source ID: NCT01471275
Associated Drug: Metformin
Title: Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus ;Obesity,High Triglycerides;TCM
Interventions: DRUG: Metformin|DRUG: Jiangtangtiaozhi decoction
Outcome Measures: Primary: Glycosylated hemoglobin, 12 weeks | Secondary: Waistline, 4 weeks|Triglycerides, 12 weeks|Liver function, 4 weeks|Renal function, 4 weeks|Whole blood cell analysis, 4 weeks|Urinalysis, 12 weeks|Adverse events recorded, 4 weeks
Sponsor/Collaborators: Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 450
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2011-11
Completion Date: 2013-12
Results First Posted:
Last Update Posted: 2011-12-06
Locations: Guang'anmen Hospital of China Academy ofChinese Medical Sciences, Beijing, Beijing, China|Baoding Hospital of TCM, Baoding, Hebei, China|Affiliated Hospital of Changchun University of TCM, Changchun, Jilin, China|Qinghai Provence Hospital of TCM, Xining, Qinghai, China|Tianjin Dagang Hospital, Dagang, Tianjin, China|Tianjin University of Traditional Chinese Medicine, First Affiliated Hospital, Tianjin, Tianjin, China|Yichang City Yiling Hospital, Yichang, Yichang, China|Hangzhou Hospital of TCM, Hangzhou, Zhejiang, China
URL: https://clinicaltrials.gov/show/NCT01471275